NCT02526641View on ClinicalTrials.gov

Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

November 30, 2020

Conditions
Hepatitis C
Interventions
PROCEDURE

Functional Hepatic Nitrogen Clearance (FHNC)

PROCEDURE

Galactose Elimination Capacity (GEC)

PROCEDURE

Liver vein catheterization

Trial Locations (1)

8000

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

AbbVie

INDUSTRY

lead

University of Aarhus

OTHER